Transcription factor AP-2 gamma (TFAP2C) transcriptionally activates lncRNA PCAT1 to suppress ferroptosis of prostate cancer cells by interacting with c-Myc [131]. The gene discussed is TFAP2C; the disease is prostate carcinoma.